A Phase 3, Randomized, Double Blind, Placebo-Controlled Study to Assess the Safety, Efficacy and Pharmacokinetics of Natroba™ (Spinosad) for the Treatment of Scabies
Phase of Trial: Phase III
Latest Information Update: 03 Aug 2017
At a glance
- Drugs Spinosad (Primary)
- Indications Scabies
- Focus Adverse reactions; Registrational; Therapeutic Use
- Sponsors ParaPRO
- 02 May 2017 Status changed from not yet recruiting to recruiting.
- 13 Mar 2017 Planned number of patients changed from 75 to 120.
- 10 Mar 2017 Planned End Date changed from 1 Dec 2015 to 1 Apr 2018.